AVITA Medical Inc
NASDAQ:RCEL
Income Statement
Earnings Waterfall
AVITA Medical Inc
Revenue
|
50.1m
USD
|
Cost of Revenue
|
-7.6m
USD
|
Gross Profit
|
42.6m
USD
|
Operating Expenses
|
-84.9m
USD
|
Operating Income
|
-42.3m
USD
|
Other Expenses
|
7m
USD
|
Net Income
|
-35.4m
USD
|
Income Statement
AVITA Medical Inc
Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||
Revenue |
29
N/A
|
31
+7%
|
14
-55%
|
32
+128%
|
30
-6%
|
32
+7%
|
34
+8%
|
37
+9%
|
41
+9%
|
45
+11%
|
50
+10%
|
|
Gross Profit | ||||||||||||
Cost of Revenue |
(6)
|
(6)
|
(2)
|
(6)
|
(5)
|
(5)
|
(6)
|
(6)
|
(6)
|
(7)
|
(8)
|
|
Gross Profit |
24
N/A
|
25
+7%
|
12
-52%
|
26
+116%
|
25
-4%
|
27
+7%
|
29
+8%
|
32
+11%
|
34
+8%
|
38
+11%
|
43
+11%
|
|
Operating Income | ||||||||||||
Operating Expenses |
(50)
|
(47)
|
(26)
|
(55)
|
(55)
|
(56)
|
(56)
|
(59)
|
(67)
|
(74)
|
(85)
|
|
Selling, General & Administrative |
(37)
|
(34)
|
(19)
|
(41)
|
(43)
|
(44)
|
(45)
|
(48)
|
(53)
|
(59)
|
(66)
|
|
Research & Development |
(15)
|
(15)
|
(8)
|
(15)
|
(14)
|
(15)
|
(14)
|
(15)
|
(17)
|
(17)
|
(21)
|
|
Other Operating Expenses |
2
|
2
|
1
|
2
|
2
|
2
|
3
|
3
|
3
|
2
|
1
|
|
Operating Income |
(26)
N/A
|
(22)
+16%
|
(14)
+35%
|
(29)
-99%
|
(30)
-5%
|
(30)
+1%
|
(27)
+8%
|
(27)
-1%
|
(32)
-18%
|
(36)
-11%
|
(42)
-18%
|
|
Pre-Tax Income | ||||||||||||
Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
|
Non-Reccuring Items |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
3
|
8
|
|
Pre-Tax Income |
(27)
N/A
|
(22)
+16%
|
(14)
+35%
|
(29)
-98%
|
(30)
-5%
|
(30)
+1%
|
(27)
+11%
|
(26)
+1%
|
(30)
-16%
|
(34)
-10%
|
(35)
-5%
|
|
Net Income | ||||||||||||
Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Income from Continuing Operations |
(27)
|
(22)
|
(14)
|
(29)
|
(30)
|
(30)
|
(27)
|
(26)
|
(31)
|
(34)
|
(35)
|
|
Net Income (Common) |
(27)
N/A
|
(22)
+16%
|
(14)
+35%
|
(29)
-98%
|
(30)
-5%
|
(30)
+1%
|
(27)
+10%
|
(26)
+1%
|
(31)
-16%
|
(34)
-10%
|
(35)
-5%
|
|
EPS (Diluted) |
-1.17
N/A
|
-0.89
+24%
|
-0.58
+35%
|
-1.15
-98%
|
-1.21
-5%
|
-1.19
+2%
|
-1.07
+10%
|
-1.05
+2%
|
-1.21
-15%
|
-1.33
-10%
|
-1.4
-5%
|